Joseph Beecham

Chief Scientific Officer and Senior Vice President of R&D, Nanostring Technologies, a Bruker Company (Seattle, WA)

Joined NanoString in 2012 as the Senior Vice President of R&D and is now also the company’s Chief Scientific Officer. He is a co-inventor and full commercial developer of both the GeoMx® Digital Spatial Profiler (DSP) and CosMxTM Spatial Molecular Imager (SMI). The GeoMx platform enables spatial whole transcriptomic profiling of RNA (up to 22,000-plex) and proteins (up to 570-plex) using UV-light-directed NGS-readout of standard biobanked FFPE tissue sections (Merritt et al., Nature Biotechnology, May 2020). The CosMx platform allows single-cell and subcellular spatial resolution of RNAs (up to 19,000-plex) and Proteins (up to 76-plex) (He et al., Nature Biotechnology, Dec 2022).

Dr. Beechem leads a multidisciplinary Research team at NanoString based in Seattle, WA, where he and his colleagues develop innovative technology platforms and assays based on the company’s nucleic-acid- based optical and photo-active barcodes for multiplexed quantification of biomolecules. Joe’s R&D Team now focuses 100% on technology development for unlimited-plex multi-omic spatial biology applications.

Dr. Beechem is extensively cited in the scientific literature (over 1,500 in 2023, h-index = 64) from over 400 peer-reviewed publications in diverse fields: spatial biology, cancer immunology, infectious disease, medicine, genomics, proteomics, biomathematics, physics, chemistry, and spectroscopy. Joe received a doctorate in Biology from The Johns Hopkins University and 11 years as a tenured faculty at Vanderbilt University.